Entero Healthcare [ENTERO] vs NOVELIX [NOVELIX] Detailed Stock Comparison

Entero Healthcare

NSE

NOVELIX

BSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Entero Healthcare wins in 13 metrics, NOVELIX wins in 4 metrics, with 0 ties. Entero Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Entero Healthcare	NOVELIX	Better
P/E Ratio (TTM)	51.29	516.50	Entero Healthcare
Price-to-Book Ratio	3.04	2.35	NOVELIX
Debt-to-Equity Ratio	21.76	0.00	NOVELIX
PEG Ratio	1.34	N/A	N/A
EV/EBITDA	27.52	249.71	Entero Healthcare
Profit Margin (TTM)	1.90%	0.28%	Entero Healthcare
Operating Margin (TTM)	2.94%	1.01%	Entero Healthcare
EBITDA Margin (TTM)	2.94%	1.01%	Entero Healthcare
Return on Equity	5.36%	0.68%	Entero Healthcare
Return on Assets (TTM)	3.51%	0.45%	Entero Healthcare
Free Cash Flow (TTM)	$-881.78M	$-136.91M	NOVELIX
1-Year Return	-2.62%	49.23%	NOVELIX
Price-to-Sales Ratio (TTM)	0.97	1.74	Entero Healthcare
Enterprise Value	$53.62B	$402.77M	Entero Healthcare
EV/Revenue Ratio	0.99	1.31	Entero Healthcare
Gross Profit Margin (TTM)	9.94%	2.77%	Entero Healthcare
Revenue per Share (TTM)	$1,242	$31	Entero Healthcare
Earnings per Share (Diluted)	$23.52	$0.08	Entero Healthcare
Beta (Stock Volatility)	N/A	0.32	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Entero Healthcare vs NOVELIX Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Entero Healthcare	-0.12%	-4.11%	-3.93%	-17.10%	-1.97%	-15.97%
NOVELIX	-0.73%	-5.90%	-21.44%	42.13%	49.23%	49.23%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Entero Healthcare	-2.62%	4.95%	4.95%	4.95%	4.95%	4.95%
NOVELIX	49.23%	49.23%	49.23%	49.23%	49.23%	49.23%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Entero Healthcare (ENTERO): View Full Stock Overview

NOVELIX (NOVELIX): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Entero Healthcare vs NOVELIX

Metric	ENTERO	NOVELIX
Market Information
Market Cap i	₹52.49B	₹534.47M
Market Cap Category	Mid cap	Small cap
10 Day Avg. Volume i	62,514	2,738
90 Day Avg. Volume i	76,993	23,952
Last Close	₹1,206.40	₹39.71
52 Week Range	₹1,080.00 - ₹1,584.25	₹26.61 - ₹52.79
% from 52W High	-23.85%	-24.78%
All-Time High	₹1,584.25 (Nov 04, 2024)	₹52.79 (Jul 15, 2025)
% from All-Time High	-23.85%	-24.78%
Growth Metrics
Quarterly Revenue Growth	0.28%	21.30%
Quarterly Earnings Growth	0.38%	-0.34%
Financial Health
Profit Margin (TTM) i	0.02%	0.00%
Operating Margin (TTM) i	0.03%	0.01%
Return on Equity (TTM) i	0.05%	0.01%
Debt to Equity (MRQ) i	21.76	0.00
Cash & Liquidity
Book Value per Share (MRQ)	₹396.70	₹17.59
Cash per Share (MRQ)	₹73.09	₹0.93
Operating Cash Flow (TTM) i	₹-1,784,970,000	₹-136,844,992
Levered Free Cash Flow (TTM) i	₹948.20M	₹-159,493,200
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Entero Healthcare vs NOVELIX

Metric	ENTERO	NOVELIX
Price Ratios
P/E Ratio (TTM) i	51.29	516.50
Forward P/E i	23.58	N/A
PEG Ratio i	1.34	N/A
Price to Sales (TTM) i	0.97	1.74
Price to Book (MRQ) i	3.04	2.35
Market Capitalization
Market Capitalization i	₹52.49B	₹534.47M
Enterprise Value i	₹53.62B	₹402.77M
Enterprise Value Metrics
Enterprise to Revenue i	0.99	1.31
Enterprise to EBITDA i	27.52	249.71
Risk & Other Metrics
Beta i	N/A	0.32
Book Value per Share (MRQ) i	₹396.70	₹17.59

Financial Statements Comparison: Entero Healthcare vs NOVELIX

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ENTERO	NOVELIX
Revenue/Sales i	₹14.04B	₹208.61M
Cost of Goods Sold i	₹12.64B	₹202.84M
Gross Profit i	₹1.40B	₹5.77M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹412.02M	₹2.11M
EBITDA i	₹558.96M	₹2.18M
Pre-Tax Income i	₹363.63M	₹2.11M
Income Tax i	₹61.31M	₹495,000
Net Income (Profit) i	₹302.32M	₹1.61M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ENTERO	NOVELIX
Cash & Equivalents i	₹2.29B	₹6.79M
Total Current Assets i	₹20.76B	₹269.33M
Total Current Liabilities i	₹8.45B	₹96.67M
Long-Term Debt i	₹670.18M	₹0
Total Shareholders Equity i	₹17.70B	₹175.39M
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹1.32B	₹1.86M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ENTERO	NOVELIX
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	ENTERO	NOVELIX
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	62,514	2,738
Average Daily Volume (90 Day) i	76,993	23,952
Shares Outstanding i	43.51M	9.95M
Float Shares i	13.64M	1.64M
% Held by Insiders i	0.63%	0.64%
% Held by Institutions i	0.22%	0.00%

Dividend Analysis & Yield Comparison: Entero Healthcare vs NOVELIX

Metric	ENTERO	NOVELIX
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Entero Healthcare [ENTERO] vs NOVELIX [NOVELIX] Detailed Stock Comparison